Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22773551 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Erlotinib

Indicates status has not been verified in more than two years